Rating Change
Needham analysts reiterated a Buy rating on Personalis, Inc. (NASDAQ:PSNL) on July 17, 2026.
Rating Change Needham analysts reiterated a Buy rating on Personalis, Inc. (NASDAQ:PSNL) on July 17, 2026. Market Context Personalis, Inc.

Needham analysts reiterated a Buy rating on Personalis, Inc. (NASDAQ:PSNL) on July 17, 2026.
Personalis, Inc. operates in the Healthcare sector. The stock currently trades at $15.39 with a market capitalization of $824.5M.
Analyst coverage from Needham provides professional research and price targets that many institutional investors reference when making allocation decisions. The consensus of analyst opinions — along with the range of price targets — helps frame market expectations for Personalis, Inc..
Analyst ratings and price targets are one input among many for investment decisions. Historical studies show that consensus analyst recommendations have mixed predictive power on their own, but significant changes in consensus — such as multiple upgrades or downgrades in a short period — can be more meaningful signals.
Among the 10 most recent ratings: 6 Buy, 4 Hold, 0 Sell.
| Date | Firm | Rating | Price Target |
|---|---|---|---|
| Jul 17, 2026 | Needham | Buy | N/A |
| Jul 09, 2026 | Morgan Stanley | Equal-Weight | N/A |
| May 12, 2026 | Morgan Stanley | Equal-Weight | N/A |
| May 11, 2026 | BTIG | Buy | N/A |
| Mar 05, 2026 | Morgan Stanley | Equal-Weight | N/A |
Related Tools: Analyst Ratings Dashboard | View PSNL Stock Page
A Buy rating from Needham reflects the analyst's outlook on Personalis, Inc. (NASDAQ:PSNL). Analyst ratings are one factor investors consider alongside earnings, valuation, and sector trends.
Browse recent upgrades and downgrades on our Analyst Ratings Dashboard or the PSNL forecast page.
Current market data
NASDAQ · PSNL
$14.42
Down: -$0.38 · -2.64%
Live quote updated
Keep reading